Skip to the page

Data / Form D filings / Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc.: Form D filings

Diasome Pharmaceuticals, Inc., a health care company in Cleveland, OH, filed 8 Form D notices with the SEC between 2009 and 2024. The latest, on August 15, 2024, reports $3.1 million sold of a $15.6 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10000 CEDAR AVENUE, SUITE 6, Cleveland, OH, 44106
Phone
(216) 444-7110
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1411617

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 15, 2024New notice$15,555,620$3,090,740$12,464,8804Jul 31, 2024sec.gov
Jun 30, 2023New notice$14,999,998$8,999,998$6,000,0002Jun 22, 2023sec.gov
Sep 8, 2022New notice$19,092,510$16,724,591$2,367,91940Aug 26, 2022sec.gov
Dec 23, 2020New notice$5,000,000$1,500,000$3,500,0006Sep 21, 2020sec.gov
Apr 1, 2020New notice$2,897,788$2,885,788$12,00020Mar 17, 2020sec.gov
Oct 26, 2018New notice$18,638,000$12,084,000$6,554,00022Oct 12, 2018sec.gov
Jan 17, 2017New notice$8,000,000$4,350,000$3,650,0004Dec 16, 2016sec.gov
Apr 13, 2009Amendment$13,400,000$12,900,000$500,0009Mar 27, 2008sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter Blair TollmanDirector
Robert GehoExecutive Officer, Director
Frank Blair McCaneyDirector
W. Blair GehoExecutive Officer, Director
Thomas Blair McDonaldDirector
Cosme Blair OrdonezDirector

Other health care companies in Ohio that filed recently

Every Form D from the week of Aug 12, 2024 · All recent filings in Ohio · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Diasome Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.